← Search & browse all drugs
BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › I.V. SOLUTIONS › Solutions for parenteral nutrition
carbohydrates
B05BA03
Forms & Strengths
- Intravenous infusion: 5%, 10%, 20%, 50% Dextrose in Water (D5W, D10W, D20W, D50W)
- Oral solution/gel: Various concentrations for hypoglycemia
Adult Dosing
- Hypoglycemia: 10-25 g IV of D50W, repeat as needed
- Parenteral nutrition: 2.5 to 5 mg/kg/min IV, titrated based on metabolic response and glycemic control (max generally 5-7 mg/kg/min)
Pediatric Dosing
- Neonates/Infants (Hypoglycemia): 200-500 mg/kg IV (2-5 mL/kg of D10W) slowly
- Children (Hypoglycemia): 0.5-1 g/kg IV of D25W or D50W diluted
- Parenteral nutrition: Initial 4-8 mg/kg/min IV, adjusted to maintain normoglycemia
Indications
- Treatment of severe hypoglycemia
- Caloric source in parenteral nutrition
- Management of insulin-induced hypoglycemia
Mechanism of Action
- Metabolized to carbon dioxide and water, providing a source of dietary calories
- Rapidly elevates blood glucose concentrations, halting catabolism and reversing hypoglycemia
Contraindications
- Anuria or severe renal failure where fluid administration cannot be tolerated
- Intracranial or intraspinal hemorrhage
- Severe dehydration
- Delirium tremens with dehydration
Adverse Reactions
- Hyperglycemia and glycosuria
- Fluid overload, pulmonary edema, and peripheral edema
- Electrolyte disturbances (hypokalemia, hypomagnesemia, hypophosphatemia)
- Venous irritation, thrombosis, and extravasation necrosis (with hypertonic solutions)
Drug Interactions
- Insulin and oral antidiabetic agents antagonize the hyperglycemic effect
- Corticosteroids may increase blood glucose, requiring careful monitoring
- Incompatible with certain drugs in IV admixture (e.g., blood products due to pseudoagglutination)
Curated Content: Needs Vetting Before Put to Clinical Use